Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia. [electronic resource]
Producer: 20050331Description: 91-100 p. digitalISSN:- 0046-8177
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Bone Marrow -- drug effects
- Bone Marrow Cells -- cytology
- Clinical Trials as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Piperazines -- therapeutic use
- Pyrimidines -- therapeutic use
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.